Gene therapy trial targets blinding eye disease
NCT ID NCT06018558
First seen Jan 04, 2026 · Last updated Apr 28, 2026 · Updated 16 times
Summary
This study tests a new treatment called OCU410 for people with geographic atrophy, a severe form of dry age-related macular degeneration that causes vision loss. The trial involves 60 adults aged 50 and older and aims to see if the treatment is safe and can slow the growth of damaged areas in the eye. OCU410 is given as a single injection under the retina.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A) Retina Foundation of the Southwest
Dallas, Texas, 75231, United States
-
Advanced Research, LLC
Coral Springs, Florida, 33067, United States
-
Associated Retina Consultants
Phoenix, Arizona, 85020, United States
-
B) Retina Consultants of Texas
Bellaire, Texas, 77401, United States
-
Duke Eye Center
Durham, North Carolina, 27710, United States
-
Gundersen Health System
La Crosse, Wisconsin, 54601, United States
-
Mid Atlantic Retina
Cherry Hill, New Jersey, 08034, United States
-
Miidwest Eye Institute
Carmel, Indiana, 46290, United States
-
Mississippi Retina Associates
Jackson, Mississippi, 39202, United States
-
The Retina Institute
St Louis, Missouri, 63128, United States
-
The University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
-
Valley retina Institute
McAllen, Texas, 78503, United States
Conditions
Explore the condition pages connected to this study.